Systolic Anterior Motion (SAM) in Hypertrophic Cardiomyopathy

Systolic Anterior Motion (SAM) in Hypertrophic Cardiomyopathy

Definition

Systolic anterior motion (SAM) refers to anterior displacement of the mitral valve apparatus toward the interventricular septum during systole, leading to dynamic left ventricular outflow tract (LVOT) obstruction and mitral regurgitation. It is a hallmark pathophysiologic feature of hypertrophic cardiomyopathy (HCM), particularly the obstructive phenotype.

---

Pathophysiology of SAM

SAM is not simply a consequence of septal hypertrophy; it is the result of complex interactions between ventricular geometry, mitral valve anatomy, and flow dynamics.

Key mechanisms include:

1. Venturi and Drag Forces

High-velocity systolic flow through a narrowed LVOT creates drag forces that pull the anterior mitral leaflet toward the septum.

2. Mitral Valve Abnormalities

Elongated anterior mitral leaflet

Anterior displacement of papillary muscles

Increased leaflet slack

These abnormalities predispose the leaflet to systolic displacement.

3. Septal Hypertrophy

Asymmetric basal septal hypertrophy narrows the LVOT and amplifies flow velocity, facilitating SAM.

4. Small LV Cavity & Hypercontractility

Reduced LV end-systolic dimension and vigorous contraction increase leaflet–septal interaction.

---

Hemodynamic Consequences

Dynamic LVOT obstruction

Late-peaking systolic pressure gradient

Secondary (posteriorly directed) mitral regurgitation

Reduced forward stroke volume

Hypotension and syncope during exertion

LVOT gradient ≥30 mmHg at rest or ≥50 mmHg with provocation is considered hemodynamically significant.

---

Echocardiographic Features of SAM

2D Echocardiography

Parasternal long-axis view shows anterior mitral leaflet contacting or approaching the septum in mid-to-late systole

Basal septal hypertrophy

Small LV cavity

M-Mode

Classic early systolic anterior motion of the mitral leaflet toward the septum

Septal contact correlates with severity of obstruction

Color Doppler

Turbulent flow in LVOT

Posteriorly directed mitral regurgitation jet

Continuous-Wave Doppler

Late-peaking (“dagger-shaped”) systolic LVOT velocity profile

Gradient increases with provocation (Valsalva, standing, exercise)

---

Provocative Maneuvers to Unmask SAM

Valsalva maneuver

Standing from squatting

Exercise stress echocardiography

Post–extrasystolic potentiation

These maneuvers reduce preload or afterload, increasing SAM severity and LVOT gradient.

---

Differential Diagnosis of SAM

SAM can also be seen in conditions other than HCM:

Hyperdynamic LV states (sepsis, dehydration)

Post–mitral valve repair

Takotsubo syndrome

Acute myocardial infarction with basal hyperkinesis

After inotropic therapy

Clinical context and septal morphology help distinguish true HCM-related SAM.

---

Clinical Implications

Presence of SAM is associated with:

Exertional dyspnea

Angina

Presyncope or syncope

Increased risk of heart failure symptoms

Severity of symptoms often correlates better with LVOT gradient than with septal thickness alone.

---

Management of SAM in HCM

1. Medical Therapy (First Line)

Beta-blockers: reduce contractility and heart rate

Non-dihydropyridine calcium channel blockers (verapamil, diltiazem)

Disopyramide (negative inotrope, reduces SAM)

2. Avoid

Dehydration

Vasodilators

Nitrates

High-dose diuretics

Positive inotropes

3. Septal Reduction Therapy (for refractory cases)

Surgical septal myectomy

Alcohol septal ablation

These reduce LVOT obstruction and eliminate SAM by enlarging the outflow tract.

---

Role of Cardiac MRI

Detailed assessment of mitral valve and papillary muscle anatomy

Quantification of septal hypertrophy

Detection of myocardial fibrosis (risk stratification)

---

Key Takeaways

SAM is central to the pathophysiology of obstructive HCM

It results from combined mitral valve abnormalities, septal hypertrophy, and altered flow dynamics

Echocardiography is the cornerstone of diagnosis and gradient assessment

Management focuses on reducing contractility and LVOT obstruction

Persistent symptomatic SAM warrants septal reduction therapy

---

For more cardiology-focused, guideline-based articles and infographics, visit drmusmanjaved.com